Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 16:27 | 5/15/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Sachdev Amit | MA | O | EVP Chie | 3 | S | -3,083 | 422.86 | 0 | -7 | 71 | D | |||||||||||||||
5/17/24 16:24 | 5/15/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Arbuckle Stuart A | MA | O | EVP,COO | 4 | S | -5,714 | 422.93 | 0 | -14 | 63 | D | |||||||||||||||
5/17/24 16:22 | 5/15/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Altshuler David | MA | O | EVP, Chi | 4 | S | -4,778 | 422.94 | 0 | -11 | 37 | D | |||||||||||||||
5/3/24 16:05 | 5/2/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Bhatia Sangeeta N. | MA | D | 1 | S | -188 | 402.95 | 0 | 0 | 4 | D | ||||||||||||||||
4/3/24 16:02 | 4/2/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Ambrose Kristen | MA | O | SVP,Chie | 2 | S | -476 | 424.27 | 0 | -1 | 8 | D | |||||||||||||||
2/27/24 17:02 | 2/26/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Tatsis Ourania | MA | O | EVP,Chie | 3 | S | -505 | 422.54 | 0 | -1 | 60 | D | |||||||||||||||
2/27/24 16:44 | 2/26/24 | VRTX | Health | Drug | Pharmaceutical Preparations | Atkinson Edward Morrow III | MA | O | EVP,Chie | 3 | S | -1,219 | 422.70 | 0 | -3 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |